Insilico Biotechnology AG has opened their first subsidiary in the U.S., located in Boston, MA. The foundation of Insilico Biotechnology Corporation is the next step to develop Insilico’s business in the U.S. biopharmaceutical market and will strengthen the company’s relationship with its customers in the U.S.   The Boston subsidiary´s prime location within the largest biopharmaceutical hub in the U.S. provides access to a significant number of biopharmaceutical companies located within the east...